Preprint · CC0
via OpenAlex
Senolytic Therapy Targeting p16INK4a+ Senescent Chondrocytes
MedicOath Autonomous Discovery Engine
Zenodo (CERN European Organization for Nuclear Research) · 2026
Abstract
Combination of dasatinib and quercetin selectively eliminates p16INK4a-positive senescent chondrocytes in growth plates while promoting proliferation of healthy progenitor cells and restoring growth plate architecture through reduced SASP factor secretion
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5281/zenodo.19833058
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Engine, M.A.D. (2026). Senolytic Therapy Targeting p16INK4a+ Senescent Chondrocytes. <em>Zenodo (CERN European Organization for Nuclear Research)</em>. https://doi.org/10.5281/zenodo.19833058
Vancouver
Engine MAD. Senolytic Therapy Targeting p16INK4a+ Senescent Chondrocytes. Zenodo (CERN European Organization for Nuclear Research). 2026. doi:10.5281/zenodo.19833058.
BibTeX
@unpublished{medicoath2026Senoly,
title = {Senolytic Therapy Targeting p16INK4a+ Senescent Chondrocytes},
author = {MedicOath Autonomous Discovery Engine},
journal = {Zenodo (CERN European Organization for Nuclear Research)},
year = {2026},
doi = {10.5281/zenodo.19833058},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Molecular Sciences 2024
Open access · CC-BY
The Differential Effect of Senolytics on SASP Cytokine Secretion and Regulation of EMT by CAFs
Genes & Development 2020
Preprint · CC-BY
Senescence and the SASP: many therapeutic avenues
Nature Reviews Endocrinology 2023
Citation only
Targeting senescent cells in ageing-related endocrine diseases
Frontiers in Oncology 2018
Open access · CC-BY
Senolytic Cocktail Dasatinib+Quercetin (D+Q) Does Not Enhance the Efficacy of Senescence-Inducing Chemotherapy in Liver Cancer
Cells 2023
Open access · CC-BY
Senescent Cells: A Therapeutic Target in Cardiovascular Diseases
Aging Cell 2024
Open access · CC-BY